A naturally randomized trial evaluating the potential clinical benefit of therapies that reduce triglyceride-rich lipoproteins on the risk of coronary heart disease

28 August 2018 (15:18 - 15:26)
Organised by:
Congress Presentation Part of: Late Breaking Registry Results 2 Drug therapy ESC Premium Access ESC Congress 2018